v3.26.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Preferred Stock
Common stock
Additional paid-in capital
Accumulated other comprehensive income / (loss)
Accumulated deficit
Total
Beginning Balance at Dec. 31, 2023     $ 104,757 $ (1,578) $ (95,066) $ 8,113
Beginning Balance (in shares) at Dec. 31, 2023 13,765 889,668        
Stock-based compensation expense     829     829
Issuance of stock awards     21     21
Issuance of stock awards (in shares)   3,400        
Issuance of common stock to vendor     253     253
Issuance of common stock to vendor (in shares)   130,000        
Exchange of Preferred stock into common stock warrants (in shares) (6,356)          
Deemed dividend on extinguishment of Preferred stock     7,094   (7,094)  
Cashless exercise of warrants into common stock (in shares)   388        
Fair value of warrants reclassified from liability to equity     700     700
Issuance of common stock and warrants, net of issuance costs     6,508     6,508
Issuance of common stock and warrants, net of issuance costs (in shares)   1,619,781        
Deemed dividend on general release and amendment of Preferred stock     2,130   (2,130)  
Conversion of Preferred stock into common stock (in shares) (6,553) 749,016        
Exercise of warrants into common stock     24     24
Exercise of warrants into common stock (in shares)   197,964        
Foreign currency translation adjustment       473   473
Net loss         (10,330) (10,330)
Ending Balance at Dec. 31, 2024     122,316 (1,105) (114,620) 6,591
Ending Balance (in shares) at Dec. 31, 2024 856 3,590,217        
Stock-based compensation expense     1,040     1,040
Issuance of common stock to vendor     1,258     $ 1,258
Issuance of common stock to vendor (in shares)   490,000       490,000
Cashless exercise of warrants into common stock (in shares)   2,068,684        
Conversion of Preferred stock into common stock (in shares) (856) 690,788        
Exercise of warrants into common stock   $ 1 (1)      
Fair value of warrants issued related to note payable     159     $ 159
Foreign currency translation adjustment       (2,473)   (2,473)
Net loss         (10,509) (10,509)
Ending Balance at Dec. 31, 2025   $ 1 $ 124,772 $ (3,578) $ (125,129) $ (3,934)
Ending Balance (in shares) at Dec. 31, 2025   6,839,689